NANOFH.HE
Price:
$0.988
Market Cap:
$84.64M
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Industry
Biotechnology
IPO Date
2020-06-04
Stock Exchange
HEL
Ticker
NANOFH.HE
According to Nanoform Finland Oyj’s latest financial reports and current stock price. The company's current PE Ratio is -3.80. This represents a change of -25.66% compared to the average of -5.11 of the last 4 quarters.
The mean historical PE Ratio of Nanoform Finland Oyj over the last ten years is -65.80. The current -3.80 PE Ratio has changed 477.47% with respect to the historical average. Over the past ten years (40 quarters), NANOFH.HE's PE Ratio was at its highest in in the June 2025 quarter at -3.86. The PE Ratio was at its lowest in in the March 2019 quarter at -47.90.
Average
-65.80
Median
-20.49
Minimum
-400.59
Maximum
0
Discovering the peaks and valleys of Nanoform Finland Oyj PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.12%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -400.59
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -4.94 | -16.68% |
| 2023 | -5.93 | -46.88% |
| 2022 | -11.17 | -50.96% |
| 2021 | -22.77 | 11.12% |
| 2020 | -20.49 | -20.18% |
| 2019 | -25.67 | -74.50% |
| 2018 | -100.67 | -74.87% |
| 2017 | -400.59 | -Infinity% |
The current PE Ratio of Nanoform Finland Oyj (NANOFH.HE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.35
5-year avg
-13.06
10-year avg
-65.80
Nanoform Finland Oyj’s PE Ratio is greater than Herantis Pharma Oyj (-9.41), greater than Optomed Oyj (-12.35), less than Biohit Oyj (24.43), greater than Nexstim Plc (-347.18), greater than Modulight Oyj (-8.03),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.41 | $51.32M | |
| -12.35 | $71.70M | |
| 24.43 | $53.73M | |
| -347.18 | $104.59M | |
| -8.03 | $49.37M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanoform Finland Oyj using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanoform Finland Oyj or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nanoform Finland Oyj's PE Ratio?
How is the PE Ratio calculated for Nanoform Finland Oyj (NANOFH.HE)?
What is the highest PE Ratio for Nanoform Finland Oyj (NANOFH.HE)?
What is the 3-year average PE Ratio for Nanoform Finland Oyj (NANOFH.HE)?
What is the 5-year average PE Ratio for Nanoform Finland Oyj (NANOFH.HE)?
How does the current PE Ratio for Nanoform Finland Oyj (NANOFH.HE) compare to its historical average?